Skip to main content
Fig. 1 | Journal of Translational Medicine

Fig. 1

From: Progressive multifocal leukoencephalopathy in a patient post allo-HCT successfully treated with JC virus specific donor lymphocytes

Fig. 1

Previous MM therapy. Previous anti-MM therapy (middle row), their respective time intervals (left row) and disease responses (right row) before onset of PML. The patient received seven lines of therapy, including a tandem high dose (HD) melphalan therapy and an allo-HCT with successive interferon and donor lymphocyte infusions (DLI). The last line of therapy before JC virus reactivation contained Pomalidomide (Pom), Bortezomib, Cyclophosphamid and Daratumumab (Dara)

Back to article page

Journal of Translational Medicine

ISSN: 1479-5876

Contact us